Market Overview:
The global melatonin market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing awareness about the benefits of melatonin, rising demand for natural sleep aids, and growing aging population. The global melatonin market is segmented by type into capsule, pills, and liquid. The capsules segment is expected to dominate the market during the forecast period owing to its ease of use and convenience. By application, the hospital segment is expected to lead the market during the forecast period owing to an increase in cases of insomnia and other sleep-related disorders among patients admitted in hospitals.
Product Definition:
Melatonin is a hormone produced by the pineal gland in the brain. It helps regulate sleep and wakefulness.
Capsule:
Capsule is a small package containing active ingredients. It protects the medicines and helps it to get delivered in the human body without being damaged or changed. Capsules are mostly used for tablets, but some of them are used for capsules as well as soft gels.
Pills:
Pills is a new term in the melatonine market and it has been used for only 2-3 years. It is a capsule containing sleeping pills that are regulated by body temperature. The temperature of human blood rises during sleep, making us feel drowsy; hence the name “pill” which was earlier used for any kind of medication or drug to induce sleep.
Application Insights:
The other application segment accounted for the largest share of the global melatonine market in 2017. This is attributed to growing awareness regarding beauty and wellness among individuals from developed countries such as U.S., Germany, France, and U.K. The household application segment is expected to witness significant growth over the forecast period owing to rising awareness about health benefits associated with melatonin including better sleep quality, reduced stress levels, improved digestion and immune system functioning among others which are further likely to result in a higher demand for melatonin tablets/capsules at home or near the bedtime hours as an aid towards sleeping disorders treatment or prevention purposes globally over the coming years.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its position through the forecast period owing to increasing product consumption in countries, such as China and India. In addition, rising awareness regarding melatonin-based products among consumers is anticipated to fuel demand for tablets and capsules over the forecast period.
Europe accounted for a significant share of revenue generation in 2017 due to growing consumer awareness about sleep disorders coupled with high disposable income of individuals living there. Moreover, presence of regulatory bodies that approve Melatonine based pharmaceuticals for use as dietary supplements will support regional growth during the estimated time span.
North America held a substantial share owing to increased adoption by U.S.-based consumers duemelatonin-related benefits such as treatment of jet lag disorder and shift work sleep disorder (SWSD).
Growth Factors:
- Increasing awareness about the benefits of melatonin supplements among consumers.
- Rising demand for natural sleep aids and supplements.
- Growing number of people suffering from insomnia and other sleep disorders.
- Increasing research on the health benefits of melatonin supplements.
Scope Of The Report
Report Attributes
Report Details
Report Title
Melatonine Market Research Report
By Type
Capsule, Pills, Liquid
By Application
Hospital, Clinic, Household, Other
By Companies
Nutraceutical Corporation, Haviland Enterprises Inc., Pharma Resources International LLC, AIE Pharmaceuticals, Gemini Pharmaceuticals, Spectrum Chemical Mfg. Corp., Nutritional Supplement Manufacturers Inc., Van Wankum Ingredients, Action Labs Inc., Softgel Nutraceuticals, Norquay Technology Inc., Arnet Pharmaceutical, Twinlab Corp., Superior Supplement Manufacturing, The Chemical Co.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
224
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Melatonine Market Report Segments:
The global Melatonine market is segmented on the basis of:
Types
Capsule, Pills, Liquid
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Household, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Nutraceutical Corporation
- Haviland Enterprises Inc.
- Pharma Resources International LLC
- AIE Pharmaceuticals
- Gemini Pharmaceuticals
- Spectrum Chemical Mfg. Corp.
- Nutritional Supplement Manufacturers Inc.
- Van Wankum Ingredients
- Action Labs Inc.
- Softgel Nutraceuticals
- Norquay Technology Inc.
- Arnet Pharmaceutical
- Twinlab Corp.
- Superior Supplement Manufacturing
- The Chemical Co.
Highlights of The Melatonine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Capsule
- Pills
- Liquid
- By Application:
- Hospital
- Clinic
- Household
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Melatonine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Melatonin is a hormone that helps regulate the sleep-wake cycle. It is produced in the brain and is released at night. Melatonin helps to promote sleep by helping to decrease the activity of nerve cells in the brain that are responsible for wakefulness.
Some of the key players operating in the melatonine market are Nutraceutical Corporation, Haviland Enterprises Inc., Pharma Resources International LLC, AIE Pharmaceuticals, Gemini Pharmaceuticals, Spectrum Chemical Mfg. Corp., Nutritional Supplement Manufacturers Inc., Van Wankum Ingredients, Action Labs Inc., Softgel Nutraceuticals, Norquay Technology Inc., Arnet Pharmaceutical, Twinlab Corp., Superior Supplement Manufacturing, The Chemical Co..
The melatonine market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Melatonine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Melatonine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Melatonine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Melatonine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Melatonine Market Size & Forecast, 2020-2028
4.5.1 Melatonine Market Size and Y-o-Y Growth
4.5.2 Melatonine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Capsule
5.2.2 Pills
5.2.3 Liquid
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Household
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Melatonine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Melatonine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Capsule
9.6.2 Pills
9.6.3 Liquid
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Household
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Capsule
10.6.2 Pills
10.6.3 Liquid
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Household
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Capsule
11.6.2 Pills
11.6.3 Liquid
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Household
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Capsule
12.6.2 Pills
12.6.3 Liquid
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Household
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Capsule
13.6.2 Pills
13.6.3 Liquid
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Household
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Melatonine Market: Competitive Dashboard
14.2 Global Melatonine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Nutraceutical Corporation
14.3.2 Haviland Enterprises Inc.
14.3.3 Pharma Resources International LLC
14.3.4 AIE Pharmaceuticals
14.3.5 Gemini Pharmaceuticals
14.3.6 Spectrum Chemical Mfg. Corp.
14.3.7 Nutritional Supplement Manufacturers Inc.
14.3.8 Van Wankum Ingredients
14.3.9 Action Labs Inc.
14.3.10 Softgel Nutraceuticals
14.3.11 Norquay Technology Inc.
14.3.12 Arnet Pharmaceutical
14.3.13 Twinlab Corp.
14.3.14 Superior Supplement Manufacturing
14.3.15 The Chemical Co.
